Long-term Effects and Anorectal Function in Patients with Anal Squamous Cell Carcinoma Following Intensity-Modulated Radiotherapy - Report - MDSpire

Long-term Effects and Anorectal Function in Patients with Anal Squamous Cell Carcinoma Following Intensity-Modulated Radiotherapy

  • By

  • Tongzhen Xu

  • Jinming Shi

  • Huiying Ma

  • Jiacheng Shuai

  • Shulian Wang

  • Yongwen Song

  • Yueping Liu

  • Hui Fang

  • Ningning Lu

  • Shunan Qi

  • Bo Chen

  • Yirui Zhai

  • Wenwen Zhang

  • Hao Jing

  • Yexiong Li

  • Ning Li

  • Yuan Tang

  • Jing Jin

  • January 27, 2026

  • 0 min

Share

Long-term Effects and Anorectal Function in Patients with Anal Squamous Cell Carcinoma Following Intensity-Modulated Radiotherapy

Overview

This study evaluates the long-term outcomes and anorectal function in patients with anal squamous cell carcinoma (SCCA) treated with intensity-modulated radiotherapy (IMRT). The findings indicate that IMRT is associated with improved functional outcomes and manageable late toxicities over a five-year follow-up period.

Background

Anal squamous cell carcinoma (SCCA) is typically treated with definitive chemoradiation, which can lead to significant acute and late adverse events. The advent of intensity-modulated radiation therapy (IMRT) offers a potential advantage by minimizing exposure to surrounding organs while maintaining treatment efficacy. Understanding the long-term effects of IMRT on anorectal function is crucial for improving patient quality of life post-treatment.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • IMRT demonstrated a favorable long-term survival rate in patients with SCCA.
  • Late adverse events were reported at a rate of 13%, indicating manageable toxicity.
  • Anorectal function was assessed using multiple scales, with significant findings on fecal incontinence and urgency.
  • Patients reported improved quality of life compared to historical data from conventional radiotherapy.
  • IMRT allows for better sparing of organs at risk, potentially reducing treatment-related morbidity.

Clinical Implications

Clinicians should consider IMRT as a standard treatment option for patients with SCCA due to its favorable long-term outcomes and reduced toxicity. Regular assessment of anorectal function post-treatment is essential to address any complications early and improve patient quality of life.

Conclusion

The study supports the use of IMRT in treating anal squamous cell carcinoma, highlighting its benefits in long-term survival and functional outcomes. Continued monitoring and supportive care are recommended to manage late effects and enhance patient well-being.

References

  1. Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline - PubMed
  2. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial - PubMed
  3. Long-term outcomes and anorectal functional status of patients with anal squamous cell carcinoma treated with the modern technique of intensity-modulated radiotherapy - PMC
  4. The influence of anastomotic leakage on long-term cancer outcomes following low anterior resection for mid-low rectal cancer: results from an extended follow-up of a randomized controlled trial
  5. Enhancing Functional Results in Surgical Treatment of Rectal Cancer
  6. Factors Contributing to Anorectal Dysfunction Following Anterior Resection
  7. Histopathological Evaluation of Radiation-Induced Damage in the Anal Canal: A Preliminary Investigation
  8. Radiation Therapy for Anal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline - PubMed
  9. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial - PubMed
  10. Long-term outcomes and anorectal functional status of patients with anal squamous cell carcinoma treated with the modern technique of intensity-modulated radiotherapy - PMC

Original Source(s)

Related Content